Barbara Weber Tango Therapeutics, Inc. (TNGX) insider trading activity

TNGX Quotes by TradingView

Barbara Weber is Chief Executive Officer of Tango Therapeutics, Inc.. Currently has a direct ownership of 1.54 Million shares of TNGX, which is worth approximately $8.35 Million. The most recent transaction as insider was on Feb 07, 2024, when has been sold 4,457 shares (Common Stock) at a price of $12.62 per share, resulting in proceeds of $56,247. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.54M
0% 3M change
5.36% 12M change
Total Value Held $8.35 Million

Barbara Weber Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2024
SELL
Open market or private sale
$56,247 $12.62 p/Share
4,457 Reduced 0.29%
1,535,167 Common Stock
Feb 06 2024
SELL
Open market or private sale
$58,793 $12.56 p/Share
4,681 Reduced 0.3%
1,539,624 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
87,168 Added 50.0%
87,168 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
89,545 Added 5.79%
1,457,137 Common Stock

Also insider at

RVMD
Revolution Medicines, Inc. Healthcare
BW

Barbara Weber

Chief Executive Officer
Redwood City, CA

Track Institutional and Insider Activities on TNGX

Follow Tango Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

News

Receive news related to Tango Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TNGX